skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 30  for All Library Resources

Results 1 2 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans
Material Type:
Article
Add to My Research

Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans

Nature (London), 2021-08, Vol.596 (7871), p.268-272 [Peer Reviewed Journal]

2021. The Author(s). ;COPYRIGHT 2021 Nature Publishing Group ;Copyright Nature Publishing Group Aug 12, 2021 ;The Author(s) 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03681-2 ;PMID: 34107529

Full text available

2
mRNA-1273 vaccine-induced antibodies maintain Fc effector functions across SARS-CoV-2 variants of concern
Material Type:
Article
Add to My Research

mRNA-1273 vaccine-induced antibodies maintain Fc effector functions across SARS-CoV-2 variants of concern

Immunity (Cambridge, Mass.), 2022-02, Vol.55 (2), p.355-365.e4 [Peer Reviewed Journal]

2022 The Authors ;Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved. ;2022 The Authors 2022 ;ISSN: 1074-7613 ;EISSN: 1097-4180 ;DOI: 10.1016/j.immuni.2022.01.001 ;PMID: 35090580

Full text available

3
Evolution of functional antibodies following acute Epstein-Barr virus infection
Material Type:
Article
Add to My Research

Evolution of functional antibodies following acute Epstein-Barr virus infection

PLoS pathogens, 2022-09, Vol.18 (9), p.e1010738-e1010738 [Peer Reviewed Journal]

COPYRIGHT 2022 Public Library of Science ;2022 Karsten et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 Karsten et al 2022 Karsten et al ;ISSN: 1553-7374 ;ISSN: 1553-7366 ;EISSN: 1553-7374 ;DOI: 10.1371/journal.ppat.1010738 ;PMID: 36067220

Full text available

4
Persistence of viral RNA in lymph nodes in ART-suppressed SIV/SHIV-infected Rhesus Macaques
Material Type:
Article
Add to My Research

Persistence of viral RNA in lymph nodes in ART-suppressed SIV/SHIV-infected Rhesus Macaques

Nature communications, 2021-03, Vol.12 (1), p.1474-1474, Article 1474 [Peer Reviewed Journal]

The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-021-21724-0 ;PMID: 33674572

Full text available

5
Selective transfer of maternal antibodies in preterm and fullterm children
Material Type:
Article
Add to My Research

Selective transfer of maternal antibodies in preterm and fullterm children

Scientific reports, 2022-09, Vol.12 (1), p.14937-14937, Article 14937 [Peer Reviewed Journal]

2022. The Author(s). ;The Author(s) 2022 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-022-18973-4 ;PMID: 36056073

Full text available

6
Hybrid Immunity Shifts the Fc-Effector Quality of SARS-CoV-2 mRNA Vaccine-Induced Immunity
Material Type:
Article
Add to My Research

Hybrid Immunity Shifts the Fc-Effector Quality of SARS-CoV-2 mRNA Vaccine-Induced Immunity

mBio, 2022-10, Vol.13 (5), p.e0164722-e0164722 [Peer Reviewed Journal]

Copyright © 2022 Bowman et al. ;Copyright © 2022 Bowman et al. 2022 Bowman et al. ;ISSN: 2150-7511 ;EISSN: 2150-7511 ;DOI: 10.1128/mbio.01647-22 ;PMID: 36000735

Full text available

7
Innate lymphoid cells and COVID-19 severity in SARS-CoV-2 infection
Material Type:
Article
Add to My Research

Innate lymphoid cells and COVID-19 severity in SARS-CoV-2 infection

eLife, 2022-03, Vol.11 [Peer Reviewed Journal]

2022, Silverstein et al. ;2022, Silverstein et al 2022 Silverstein et al ;ISSN: 2050-084X ;EISSN: 2050-084X ;DOI: 10.7554/eLife.74681 ;PMID: 35275061

Full text available

8
A Mycobacterium tuberculosis Specific IgG3 Signature of Recurrent Tuberculosis
Material Type:
Article
Add to My Research

A Mycobacterium tuberculosis Specific IgG3 Signature of Recurrent Tuberculosis

Frontiers in immunology, 2021-09, Vol.12, p.729186-729186 [Peer Reviewed Journal]

Copyright © 2021 Fischinger, Cizmeci, Shin, Davies, Grace, Sivro, Yende-Zuma, Streeck, Fortune, Lauffenburger, Naidoo and Alter. ;Copyright © 2021 Fischinger, Cizmeci, Shin, Davies, Grace, Sivro, Yende-Zuma, Streeck, Fortune, Lauffenburger, Naidoo and Alter 2021 Fischinger, Cizmeci, Shin, Davies, Grace, Sivro, Yende-Zuma, Streeck, Fortune, Lauffenburger, Naidoo and Alter ;ISSN: 1664-3224 ;EISSN: 1664-3224 ;DOI: 10.3389/fimmu.2021.729186 ;PMID: 34630406

Full text available

9
Federated learning for diagnosis of age-related macular degeneration
Material Type:
Article
Add to My Research

Federated learning for diagnosis of age-related macular degeneration

Frontiers in medicine, 2023-10, Vol.10, p.1259017-1259017 [Peer Reviewed Journal]

Copyright © 2023 Gholami, Lim, Leng, Ong, Thompson and Alam. 2023 Gholami, Lim, Leng, Ong, Thompson and Alam ;ISSN: 2296-858X ;EISSN: 2296-858X ;DOI: 10.3389/fmed.2023.1259017

Full text available

10
Robust induction of functional humoral response by a plant-derived Coronavirus-like particle vaccine candidate for COVID-19
Material Type:
Article
Add to My Research

Robust induction of functional humoral response by a plant-derived Coronavirus-like particle vaccine candidate for COVID-19

npj vaccines, 2023-02, Vol.8 (1), p.13-13, Article 13 [Peer Reviewed Journal]

2023. The Author(s). ;The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2023 ;ISSN: 2059-0105 ;EISSN: 2059-0105 ;DOI: 10.1038/s41541-023-00612-2 ;PMID: 36781879

Full text available

11
SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung
Material Type:
Article
Add to My Research

SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung

Nature communications, 2021-06, Vol.12 (1), p.3587-3587, Article 3587 [Peer Reviewed Journal]

The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-021-23942-y ;PMID: 34117252

Full text available

12
A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs
Material Type:
Article
Add to My Research

A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs

Immunity (Cambridge, Mass.), 2021-03, Vol.54 (3), p.542-556.e9 [Peer Reviewed Journal]

2021 Elsevier Inc. ;Copyright © 2021 Elsevier Inc. All rights reserved. ;2021. Elsevier Inc. ;2021 Elsevier Inc. 2021 Elsevier Inc. ;ISSN: 1074-7613 ;EISSN: 1097-4180 ;DOI: 10.1016/j.immuni.2021.02.001 ;PMID: 33631118

Full text available

13
Transverse myelitis masquerading as cauda equina syndrome, stroke and cervical myelopathy
Material Type:
Article
Add to My Research

Transverse myelitis masquerading as cauda equina syndrome, stroke and cervical myelopathy

Biomedicine (Taipei), 2020-01, Vol.10 (1), p.45-50 [Peer Reviewed Journal]

the Author(s). ;the Author(s) 2020 ;ISSN: 2211-8020 ;ISSN: 2211-8039 ;EISSN: 2211-8039 ;DOI: 10.37796/2211-8039.1005 ;PMID: 33854913

Full text available

14
Effect of host factors and COVID-19 infection on the humoral immune repertoire in treated HIV
Material Type:
Article
Add to My Research

Effect of host factors and COVID-19 infection on the humoral immune repertoire in treated HIV

JCI insight, 2023-03, Vol.8 (5) [Peer Reviewed Journal]

2023 Schnittman et al. 2023 Schnittman et al. ;ISSN: 2379-3708 ;EISSN: 2379-3708 ;DOI: 10.1172/jci.insight.166848 ;PMID: 36805331

Full text available

15
Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19
Material Type:
Article
Add to My Research

Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19

Cell, 2020-10, Vol.183 (1), p.143-157.e13 [Peer Reviewed Journal]

2020 Elsevier Inc. ;Copyright © 2020 Elsevier Inc. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020 Elsevier Inc. 2020 Elsevier Inc. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2020.08.025 ;PMID: 32877699

Digital Resources/Online E-Resources

16
When is Cherished Memory Contaminated?
Material Type:
Conference Proceeding
Add to My Research

When is Cherished Memory Contaminated?

Advances in Consumer Research, 2022, Vol.50, p.373 [Peer Reviewed Journal]

Copyright Association for Consumer Research 2022 ;ISSN: 0098-9258

Full text available

17
Robust IgM responses following intravenous vaccination with Bacille Calmette-Guérin associate with prevention of Mycobacterium tuberculosis infection in macaques
Material Type:
Article
Add to My Research

Robust IgM responses following intravenous vaccination with Bacille Calmette-Guérin associate with prevention of Mycobacterium tuberculosis infection in macaques

Nature immunology, 2021-12, Vol.22 (12), p.1515-1523 [Peer Reviewed Journal]

2021. The Author(s). ;COPYRIGHT 2021 Nature Publishing Group ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1529-2908 ;EISSN: 1529-2916 ;DOI: 10.1038/s41590-021-01066-1 ;PMID: 34811542

Full text available

18
Functional Compartmentalization of Antibodies in the Central Nervous System During Chronic HIV Infection
Material Type:
Article
Add to My Research

Functional Compartmentalization of Antibodies in the Central Nervous System During Chronic HIV Infection

The Journal of infectious diseases, 2022-09, Vol.226 (4), p.738-750 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. 2022 ;The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America and HIV Medicine Association. ;The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. ;ISSN: 0022-1899 ;EISSN: 1537-6613 ;DOI: 10.1093/infdis/jiac138 ;PMID: 35417540

Full text available

19
Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates
Material Type:
Article
Add to My Research

Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates

Science Translational Medicine, 2021-08, Vol.13 (607) [Peer Reviewed Journal]

2021. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1126/scitranslmed.abi4547

Digital Resources/Online E-Resources

20
Abstract 4559: Sprouty2 differentially regulates signaling and phenotypic responses of glioblastoma cells to DNA damaging agents and receptor kinase inhibitors
Material Type:
Article
Add to My Research

Abstract 4559: Sprouty2 differentially regulates signaling and phenotypic responses of glioblastoma cells to DNA damaging agents and receptor kinase inhibitors

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.4559-4559 [Peer Reviewed Journal]

ISSN: 0008-5472 ;EISSN: 1538-7445 ;DOI: 10.1158/1538-7445.AM2016-4559

Full text available

Results 1 - 20 of 30  for All Library Resources

Results 1 2 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (25)

Refine My Results

Creation Date 

From To
  1. Before 2016  (1)
  2. 2016 To 2019  (1)
  3. 2020 To 2020  (5)
  4. 2021 To 2022  (19)
  5. After 2022  (5)
  6. More options open sub menu

Resource Type 

  1. Articles  (26)
  2. Patents  (2)
  3. Reports  (1)
  4. Conference Proceedings  (1)
  5. More options open sub menu

Language 

  1. French  (2)
  2. Japanese  (2)
  3. More options open sub menu

Searching Remote Databases, Please Wait